Reduced order modeling and analysis of the human complement system.
Complement is an important pathway in innate immunity, inflammation, and many disease processes. However, despite its importance, there are few validated mathematical models of complement activation. In this study, we developed an ensemble of experimentally validated reduced order complement models....
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5695804?pdf=render |
id |
doaj-88cf2030ba4446c793c86c4686e1fa2f |
---|---|
record_format |
Article |
spelling |
doaj-88cf2030ba4446c793c86c4686e1fa2f2020-11-25T00:02:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011211e018737310.1371/journal.pone.0187373Reduced order modeling and analysis of the human complement system.Adithya SagarWei DaiMason MinotRachel LeCoverJeffrey D VarnerComplement is an important pathway in innate immunity, inflammation, and many disease processes. However, despite its importance, there are few validated mathematical models of complement activation. In this study, we developed an ensemble of experimentally validated reduced order complement models. We combined ordinary differential equations with logical rules to produce a compact yet predictive model of complement activation. The model, which described the lectin and alternative pathways, was an order of magnitude smaller than comparable models in the literature. We estimated an ensemble of model parameters from in vitro dynamic measurements of the C3a and C5a complement proteins. Subsequently, we validated the model on unseen C3a and C5a measurements not used for model training. Despite its small size, the model was surprisingly predictive. Global sensitivity and robustness analysis suggested complement was robust to any single therapeutic intervention. Only the simultaneous knockdown of both C3 and C5 consistently reduced C3a and C5a formation from all pathways. Taken together, we developed a validated mathematical model of complement activation that was computationally inexpensive, and could easily be incorporated into pre-existing or new pharmacokinetic models of immune system function. The model described experimental data, and predicted the need for multiple points of therapeutic intervention to fully disrupt complement activation.http://europepmc.org/articles/PMC5695804?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Adithya Sagar Wei Dai Mason Minot Rachel LeCover Jeffrey D Varner |
spellingShingle |
Adithya Sagar Wei Dai Mason Minot Rachel LeCover Jeffrey D Varner Reduced order modeling and analysis of the human complement system. PLoS ONE |
author_facet |
Adithya Sagar Wei Dai Mason Minot Rachel LeCover Jeffrey D Varner |
author_sort |
Adithya Sagar |
title |
Reduced order modeling and analysis of the human complement system. |
title_short |
Reduced order modeling and analysis of the human complement system. |
title_full |
Reduced order modeling and analysis of the human complement system. |
title_fullStr |
Reduced order modeling and analysis of the human complement system. |
title_full_unstemmed |
Reduced order modeling and analysis of the human complement system. |
title_sort |
reduced order modeling and analysis of the human complement system. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Complement is an important pathway in innate immunity, inflammation, and many disease processes. However, despite its importance, there are few validated mathematical models of complement activation. In this study, we developed an ensemble of experimentally validated reduced order complement models. We combined ordinary differential equations with logical rules to produce a compact yet predictive model of complement activation. The model, which described the lectin and alternative pathways, was an order of magnitude smaller than comparable models in the literature. We estimated an ensemble of model parameters from in vitro dynamic measurements of the C3a and C5a complement proteins. Subsequently, we validated the model on unseen C3a and C5a measurements not used for model training. Despite its small size, the model was surprisingly predictive. Global sensitivity and robustness analysis suggested complement was robust to any single therapeutic intervention. Only the simultaneous knockdown of both C3 and C5 consistently reduced C3a and C5a formation from all pathways. Taken together, we developed a validated mathematical model of complement activation that was computationally inexpensive, and could easily be incorporated into pre-existing or new pharmacokinetic models of immune system function. The model described experimental data, and predicted the need for multiple points of therapeutic intervention to fully disrupt complement activation. |
url |
http://europepmc.org/articles/PMC5695804?pdf=render |
work_keys_str_mv |
AT adithyasagar reducedordermodelingandanalysisofthehumancomplementsystem AT weidai reducedordermodelingandanalysisofthehumancomplementsystem AT masonminot reducedordermodelingandanalysisofthehumancomplementsystem AT rachellecover reducedordermodelingandanalysisofthehumancomplementsystem AT jeffreydvarner reducedordermodelingandanalysisofthehumancomplementsystem |
_version_ |
1725438996017840128 |